Jointown Pharmaceutical Group Co., Ltd (600998.SS)
CNY 5.41
(-0.18%)
CNY 5.41
(-0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 149.7 Billion | 140.42 Billion | 122.4 Billion | 110.85 Billion | 99.49 Billion | 87.13 Billion |
| Cost of Revenue | 138.6 Billion | 129.47 Billion | 112.56 Billion | 100.91 Billion | 90.79 Billion | 79.61 Billion |
| Gross Profit | 11.1 Billion | 10.94 Billion | 9.83 Billion | 9.94 Billion | 8.7 Billion | 7.52 Billion |
| Operating Expenses | 9.08 Billion | 6.95 Billion | 6.36 Billion | 5.86 Billion | 5.2 Billion | 4.82 Billion |
| Selling, General and Administrative Expenses | 3.3 Billion | 4.95 Billion | 4.47 Billion | 4.17 Billion | 3.72 Billion | 3.35 Billion |
| Research and Development Expenses | 196.6 Million | 178.39 Million | 194.94 Million | 126.62 Million | 74.13 Million | 76.23 Million |
| Other Expenses | 1.45 Billion | 1.81 Billion | 1.69 Billion | 1.55 Billion | 1.4 Billion | 4.75 Million |
| Cost and Expenses | 147.11 Billion | 136.42 Billion | 118.93 Billion | 106.78 Billion | 95.99 Billion | 84.43 Billion |
| Operating Income | 3.96 Billion | 4.35 Billion | 3.59 Billion | 4.35 Billion | 3.62 Billion | 1.82 Billion |
| Interest Expense | 1.31 Billion | 1.22 Billion | 1.14 Billion | 1.02 Billion | 1.24 Billion | 889.12 Million |
| Income Tax Expense | 701.2 Million | 552.55 Million | 754.88 Million | 948.93 Million | 535.96 Million | 449.33 Million |
| Earnings before Tax | 2.99 Billion | 2.83 Billion | 3.36 Billion | 4.33 Billion | 2.31 Billion | 1.83 Billion |
| Net Income | 2.17 Billion | 2.08 Billion | 2.44 Billion | 3.07 Billion | 1.72 Billion | 1.34 Billion |
| Earnings Per Share Basic | 0.56 | 0.53 | 0.63 | 0.79 | 0.44 | 0.49 |
| Earnings Per Share Diluted | 0.56 | 0.51 | 0.63 | 0.74 | 0.40 | 0.48 |
| Weighted Average Shares Outstanding | 3.9 Billion | 3.9 Billion | 3.9 Billion | 3.9 Billion | 3.91 Billion | 2.73 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.9 Billion | 4.06 Billion | 3.9 Billion | 4.13 Billion | 4.28 Billion | 2.77 Billion |
| Gross Margin | 0.07 | 0.08 | 0.08 | 0.09 | 0.09 | 0.09 |
| EBIT Margin | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 |
| Profit Margin | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 |
| EBITDA | 5.08 Billion | 4.71 Billion | 5.16 Billion | 5.92 Billion | 4.05 Billion | 3.12 Billion |
| Earnings Before Tax Margin | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.02 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 36.25 Billion | 36.59 Billion | 40.36 Billion | 35.64 Billion | 149.7 Billion | 35 Billion |
| Cost of Revenue | 33.33 Billion | 33.65 Billion | 37.55 Billion | 33.08 Billion | 138.6 Billion | 32.4 Billion |
| Gross Profit | 2.92 Billion | 2.93 Billion | 2.8 Billion | 2.56 Billion | 11.1 Billion | 2.59 Billion |
| Operating Expenses | 1.92 Billion | 1.68 Billion | 1.91 Billion | 1.77 Billion | 7.14 Billion | 1.69 Billion |
| Selling, General and Administrative Expenses | 3.82 Billion | 1.66 Billion | 1.85 Billion | 1.69 Billion | - | 2.5 Billion |
| Research and Development Expenses | 31.33 Million | 16.49 Million | 44.25 Million | 59.63 Million | - | 43.47 Million |
| Other Expenses | -1.92 Billion | -10.59 Million | -10.01 Million | -20.63 Million | -60.11 Million | -9724.83 |
| Cost and Expenses | 35.26 Billion | 35.34 Billion | 39.47 Billion | 34.85 Billion | 145.74 Billion | 34.09 Billion |
| Operating Income | 630.86 Million | 1.24 Billion | 895.94 Million | 797.08 Million | 3.96 Billion | 557.52 Million |
| Interest Expense | 328.58 Million | 334.7 Million | 315.53 Million | 287.77 Million | 1.31 Billion | 353.05 Million |
| Income Tax Expense | 108.88 Million | 285.53 Million | 119.64 Million | 206.28 Million | 701.2 Million | 90.69 Million |
| Earnings before Tax | 629.38 Million | 967.32 Million | 642.36 Million | 601.04 Million | 2.93 Billion | 553.15 Million |
| Net Income | 488.54 Million | 669.96 Million | 537.67 Million | 350.36 Million | 2.17 Billion | 480.68 Million |
| Earnings Per Share Basic | 0.10 | 0.13 | 0.14 | 0.09 | - | 0.13 |
| Earnings Per Share Diluted | 0.10 | 0.13 | 0.14 | 0.09 | - | 0.12 |
| Weighted Average Shares Outstanding | 5.04 Billion | 5.04 Billion | 3.9 Billion | 3.9 Billion | 3.9 Billion | 3.73 Billion |
| Weighted Average Shares Outstanding (Diluted) | 5.04 Billion | 5.04 Billion | 3.9 Billion | 3.9 Billion | 3.9 Billion | 3.95 Billion |
| Gross Margin | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 |
| EBIT Margin | 0.03 | 0.04 | 0.03 | 0.03 | - | 0.03 |
| Profit Margin | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| EBITDA | 957.96 Million | 1.46 Billion | 1.16 Billion | 1 Billion | - | 963.2 Million |
| Earnings Before Tax Margin | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 |
LUCK
AMOSF
MMLP
CPPKF
IBWC
ISHANCH